T790M Plasma Testing Methodology Comparison and Clinical Validation

NCT02997501 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

PROCEDURE: T790M+ Testing
PROCEDURE: Baseline Visit Blood & Urine Testing
PROCEDURE: Baseline ECG
PROCEDURE: Visual Slit-Lamp Testing
DRUG: AZD9291 Dosing
PROCEDURE: Plasma AZD9291 testing

Sponsor

AstraZeneca

Collaborators

[object Object]